Taken together, we found that SAMD1 could inhibit cellular senescence, promote cell proliferation, cell viability, migration ability, and angiogenesis, and effectively reduce APS‐induced vascular injury and embryo loss. This evidence concerns the gene SAMD1 and autoimmune polyendocrinopathy.